Volume 2, Issue 3
Research Articlep. 393
Influence of serum epidermal growth factor on mechanical ventilation and survival in patients with acute respiratory distress syndrome
Author(s): Pooneh Salari, Mojtaba Mojtahedzadeh and Mohammad Abdollahi
Corrigendump. 510
Corrigendum: Volume 2 Issue 3
Review Articlep. 465
Platelets and new antiplatelet drugs
Author(s): Rosemarie A Reiter and Bernd Jilma
Review Articlep. 447
New advances in interleukin 1 blockade for the treatment of rheumatoid arthritis
Author(s): Joseph A Markenson
Review Articlep. 439
Interferon alpha therapy and Type 1 diabetes in patients with hepatitis C: pathophysiologic insights
Author(s): Ayse Aytaman, Gul Bahtiyar and Samy I McFarlane
Review Articlep. 425
Therapy of chronic renal insufficiency � from renal physiology to cardiovascular outcomes
Author(s): Rainer U Pliquett
Research Articlep. 415
PTH-related protein and Type 1 parathyroid hormone receptor mRNA expression in rat ventricular myocardial hypertrophy
Author(s): Antony Halapas, Peter Lembessis, Antigone Sourla, Costas Pantos, Dennis V Cokkinos and Michael Koutsilieris
Research Articlep. 407
Preparation of a polymeric reservoir naltrexone delivery device: Effect of PEG content of the PLA membrane on drug release
Author(s): Rassoul Dinarvand, Shadi H Moghadam, Pantea Sayar, Mahsa Alaee and Fatemeh Atyabi
Research Articlep. 399
Does the addition of lamotrigine to risperidone improve psychotic symptoms and cognitive impairements in chronic schizophrenia?
Author(s): Shahin Akhondzadeh, K Mackinejad, SA Ahmadi-Abhari and ZM Alem
Editorialp. 325
Cardiovascular safety of COX-2 inhibition: Time to inform systems of postmarketing surveillance?
Author(s): Robert J MacFadyen and Thomas M MacDonald
Short Reportp. 387
Chronic tendon pain: no tendinitis, but high levels of glutamate and a vasculoneural ingrowth � implications for a new treatment?
Author(s): Hakan Alfredson and Lars Ohberg
Review Articlep. 375
Are the benefits of NSAIDs to decrease the risk of Alzheimer\'s disease a MIRAGE?
Author(s): John B Standridge
Drug Evaluationp. 357
Management of community-acquired lower respiratory tract infections: gemifloxacin; a new economic paradigm
Author(s): Gary Patou, Glenn Tillotson and Joseph Blondeau
Drug Evaluationp. 349
Update on sumatriptan: new progress in migraine treatment
Author(s): Carl Dahlof
Drug Evaluationp. 343
Calcipotriol/betamethasone dipropionate: Daivobet�®
Author(s): Lyn C Guenther
Drug Evaluationp. 333
Valganciclovir for cytomegalovirus prevention and treatment
Author(s): Atul Humar
Bulletin Boardp. 329
